DIFFERENTIATION OF CYTOTOXICITY USING TARGET-CELLS LABELED WITH EUROPIUM AND SAMARIUM BY ELECTROPORATION

被引:17
作者
BOHLEN, H [1 ]
MANZKE, O [1 ]
ENGERT, A [1 ]
HERTEL, M [1 ]
HIPPLERALTENBURG, R [1 ]
DIEHL, V [1 ]
TESCH, H [1 ]
机构
[1] UNIV COLOGNE,HAUT KLIN,D-50924 COLOGNE,GERMANY
关键词
EUROPIUM; SAMARIUM; LANTHANIDE; ELECTROPORATION; CYTOTOXICITY; LYMPHOKINE-ACTIVATED KILLER CELL; BYSTANDER LYSIS;
D O I
10.1016/0022-1759(94)90283-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We report the simultaneous use of europium-DTPA (Eu-DTPA) and samarium-DTPA (Sm-DTPA) in cytotoxicity experiments to analyze simultaneously LAK and NK cell lysis and to differentiate between specific target lysis and bystander killing. The target cells were either labelled with Eu-DTPA or Sm-DTPA chelates by electroporation, which permits the use of target cell lines or primary leukemic B cells (B-CLL) that cannot be labelled by the conventional dextran-sulphate method. The release of europium and samarium reaches a maximum at comparable time intervals (2-3 h). Due to the shorter counting interval within the samarium window the labelling efficiency is about ten times less efficient compared to europium. Using europium as label for the LAK target Daudi and samarium as label for the NK sensitive cell line K562 the differentiation of LAK versus NK activity can be performed in a single culture assay. Also, the killing of B cells and bystander cells by cytotoxic T cells was analyzed in a system where T cells were redirected to B cells through CD3 x CD19 bispecific antibodies. In fact, no bystander killing was noted when bispecific antibodies were used to bridge cytotoxic T cells to the B cells. This approach provides a simple non-radioactive method for evaluating cytotoxicity against two different cells in a single culture well.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 18 条
[1]   INVIVO LOCALIZATION OF A BISPECIFIC ANTIBODY WHICH TARGETS HUMAN LYMPHOCYTES-T TO LYSE HUMAN-COLON CANCER-CELLS [J].
BARR, IG ;
MIESCHER, S ;
VONFLIEDNER, V ;
BUCHEGGER, F ;
BARRAS, C ;
LANZAVECCHIA, A ;
MACH, JP ;
CARREL, S .
INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (03) :501-507
[2]   INTERLEUKIN-2 LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY OF NON-HODGKINS-LYMPHOMA AND HODGKINS-DISEASE [J].
BERNSTEIN, ZP ;
VAICKUS, L ;
FRIEDMAN, N ;
GOLDROSEN, MH ;
WATANABE, H ;
RAHMAN, R ;
ARBUCK, SG ;
SWEENEY, J ;
VESPER, D ;
HENDERSON, ED ;
ZEFFREN, J ;
DENNIN, RA ;
LEVITT, D ;
FOON, KA .
JOURNAL OF IMMUNOTHERAPY, 1991, 10 (02) :141-146
[3]   FLUORESCENT EUROPIUM CHELATES AS TARGET-CELL MARKERS IN THE ASSESSMENT OF NATURAL-KILLER-CELL CYTOTOXICITY [J].
BLOMBERG, K ;
ULFSTEDT, AC .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 160 (01) :27-34
[4]  
BOHLEN H, 1993, IN PRESS BLOOD
[5]   DETERMINATION OF CYTOTOXIC LYMPHOCYTE-T PRECURSOR FREQUENCIES USING EUROPIUM LABELING AS A NONRADIOACTIVE ALTERNATIVE TO LABELING WITH CHROMIUM-51 [J].
BOUMA, GJ ;
VANDERMEERPRINS, PMW ;
VANBREE, FPMJ ;
VANROOD, JJ ;
CLAAS, FHJ .
HUMAN IMMUNOLOGY, 1992, 35 (02) :85-92
[6]   AN IMPROVED EUROPIUM RELEASE ASSAY FOR COMPLEMENT-MEDIATED CYTOLYSIS [J].
CUI, J ;
BYSTRYN, JC .
JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 147 (01) :13-19
[7]  
DEARMAN RJ, 1988, BLOOD, V72, P1985
[8]   BISPECIFIC MONOCLONAL-ANTIBODIES DIRECTED TO CD16 AND TO A TUMOR-ASSOCIATED ANTIGEN INDUCE TARGET-CELL LYSIS BY RESTING NK CELLS AND BY A SUBSET OF NK CLONES [J].
FERRINI, S ;
PRIGIONE, I ;
MIOTTI, S ;
CICCONE, E ;
CANTONI, C ;
CHEN, Q ;
COLNAGHI, MI ;
MORETTA, L .
INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (02) :227-233
[9]  
GARRIDO MA, 1990, J IMMUNOL, V144, P2891
[10]   DETERMINATION OF CYTO-TOXIC LYMPHOCYTE-T ACTIVITY BY TIME-RESOLVED FLUOROMETRY USING EUROPIUM-LABELED CONCANAVALIN A-STIMULATED CELLS AS TARGETS [J].
GRANBERG, C ;
BLOMBERG, K ;
HEMMILA, I ;
LOVGREN, T .
JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 114 (1-2) :191-195